The global Blood Group Typing market size was valued at US$ 1,600.0 Mn in 2018 and is projected to reach US$ 3.576 billion by 2026, expanding at a CAGR of 10.3% from 2019 to 2026.
This report studies the current as well as future prospects of the global blood group typing market. Stakeholders of this report include companies and intermediaries engaged in the manufacture, commercialization, and provision of products for blood group typing and new players planning to enter the market. This report comprises an elaborate executive summary along with a market snapshot providing overall information of various segments and sub-segments considered in the scope of the study. This section also provides the overall information and data analysis of the global blood group typing market with respect to the leading segments based on product, technique, test, end-user, and region.
Based on product, the global blood group typing market has been categorized into instruments [automated, semi-automated, and manual], consumables (reagent, test kits, antisera, others) and services. In terms of technique, the market has been classified into PCR-based, microarray-based, assay-based technique, and massively parallel technique. Based on test, the market has been segregated into antibody screening, HLA typing, ABO blood test, cross matching test, and antigen typing. Based on end-user, the global blood group typing market has been divided into hospitals, clinical laboratories, blood bank, and others.
Each of the segments has been extensively analyzed based on market related factors such as incidence and prevalence of major chronic diseases. Moreover, historical year-on-year growth has been taken into consideration while estimating the market size. The market size and forecast in terms of US$ Mn for each segment have been provided for the period from 2016 to 2026. The report also provides the compound annual growth rate (CAGR %) for each market segment for the forecast period from 2019 to 2026, considering 2018 as the base year.
The overview section of the report analyzes market dynamics such as drivers, restraints, and opportunities that currently have a strong impact on the blood group typing market and is likely to influence the market in the near future. Market attractiveness analysis has been provided in the overview section in order to explain the intensity of competition in the market across different regions. The competitive scenario among different market players has been evaluated through market share analysis in the competitive landscape section of the report. All these factors are expected to help market players take strategic decisions in order to strengthen their positions and expand their shares in the global blood group typing market.
In terms of geography, the global blood group typing market has been segmented into five major regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The market size and forecast for each of these regions have been provided for the period from 2016 to 2026, along with their respective CAGRs for the forecast period from 2019 to 2026, considering 2018 as the base year. The report also provides the market size and forecast for major countries in the respective regions. A detailed qualitative analysis of factors responsible for driving and restraining market growth and future opportunities has been provided in the market overview section. This section of the report also provides market attractiveness analysis, Porter’s Five Forces analysis, and market share Analysis, by key players, thereby presenting a thorough analysis of the overall competitive scenario in the global blood group typing market.
Key players operating in the global blood group typing market include Grifols, S. A., Bio-Rad Laboratories, Inc., Merck KGaA, Ortho Clinical Diagnostics, QUOTIENT LIMITED, BAG Health Care GmbH, Immucor, Inc., Beckman Coulter, Inc. (Danaher Corporation), Agena Bioscience, Inc., Rapid Labs Ltd, and Novacyt Group.
Report Segmentation:
Global Blood Group Typing Market, by Product
Global Blood Group Typing Market, by Technique
Global Blood Group Typing Market, by Test
Global Blood Group Typing Market, by End-user
Global Blood Group Typing Market, by Region
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global Blood Group Typing Market, By Product
7.1. Blood Group Typing Market, By Product, 2021-2028
7.1.1. Consumables
7.1.1.1. Market Revenue and Forecast (2016-2028)
7.1.2. Instruments
7.1.2.1. Market Revenue and Forecast (2016-2028)
7.1.3. Services
7.1.3.1. Market Revenue and Forecast (2016-2028)
Chapter 8. Global Blood Group Typing Market, By Technique
8.1. Blood Group Typing Market, By Technique, 2021-2028
8.1.1. PCR-based and Microarray Techniques
8.1.1.1. Market Revenue and Forecast (2016-2028)
8.1.2. Assay-based Techniques
8.1.2.1. Market Revenue and Forecast (2016-2028)
8.1.3. Massively Parallel Sequencing Techniques
8.1.3.1. Market Revenue and Forecast (2016-2028)
8.1.4. Other Techniques
8.1.4.1. Market Revenue and Forecast (2016-2028)
Chapter 9. Global Blood Group Typing Market, By Test Type
9.1. Blood Group Typing Market, By Test Type, 2021-2028
9.1.1. Antibody Screening
9.1.1.1. Market Revenue and Forecast (2016-2028)
9.1.2. HLA Typing
9.1.2.1. Market Revenue and Forecast (2016-2028)
9.1.3. Cross-matching Tests
9.1.3.1. Market Revenue and Forecast (2016-2028)
9.1.4. ABO Blood Tests
9.1.4.1. Market Revenue and Forecast (2016-2028)
9.1.5. Antigen Typing
9.1.5.1. Market Revenue and Forecast (2016-2028)
Chapter 10. Global Blood Group Typing Market, Regional Estimates and Trend Forecast
10.1. North America
10.1.1. Market Revenue and Forecast, By Product (2016-2028)
10.1.2. Market Revenue and Forecast, By Technique (2016-2028)
10.1.3. Market Revenue and Forecast, By Test Type (2016-2028)
10.1.4. U.S.
10.1.4.1. Market Revenue and Forecast, By Product (2016-2028)
10.1.4.2. Market Revenue and Forecast, By Technique (2016-2028)
10.1.4.3. Market Revenue and Forecast, By Test Type (2016-2028)
10.1.5. Rest of North America
10.1.5.1. Market Revenue and Forecast, By Product (2016-2028)
10.1.5.2. Market Revenue and Forecast, By Technique (2016-2028)
10.1.5.3. Market Revenue and Forecast, By Test Type (2016-2028)
10.2. Europe
10.2.1. Market Revenue and Forecast, By Product (2016-2028)
10.2.2. Market Revenue and Forecast, By Technique (2016-2028)
10.2.3. Market Revenue and Forecast, By Test Type (2016-2028)
10.2.4. UK
10.2.4.1. Market Revenue and Forecast, By Product (2016-2028)
10.2.4.2. Market Revenue and Forecast, By Technique (2016-2028)
10.2.4.3. Market Revenue and Forecast, By Test Type (2016-2028)
10.2.5. Germany
10.2.5.1. Market Revenue and Forecast, By Product (2016-2028)
10.2.5.2. Market Revenue and Forecast, By Technique (2016-2028)
10.2.5.3. Market Revenue and Forecast, By Test Type (2016-2028)
10.2.6. France
10.2.6.1. Market Revenue and Forecast, By Product (2016-2028)
10.2.6.2. Market Revenue and Forecast, By Technique (2016-2028)
10.2.6.3. Market Revenue and Forecast, By Test Type (2016-2028)
10.2.7. Rest of Europe
10.2.7.1. Market Revenue and Forecast, By Product (2016-2028)
10.2.7.2. Market Revenue and Forecast, By Technique (2016-2028)
10.2.7.3. Market Revenue and Forecast, By Test Type (2016-2028)
10.3. APAC
10.3.1. Market Revenue and Forecast, By Product (2016-2028)
10.3.2. Market Revenue and Forecast, By Technique (2016-2028)
10.3.3. Market Revenue and Forecast, By Test Type (2016-2028)
10.3.4. India
10.3.4.1. Market Revenue and Forecast, By Product (2016-2028)
10.3.4.2. Market Revenue and Forecast, By Technique (2016-2028)
10.3.4.3. Market Revenue and Forecast, By Test Type (2016-2028)
10.3.5. China
10.3.5.1. Market Revenue and Forecast, By Product (2016-2028)
10.3.5.2. Market Revenue and Forecast, By Technique (2016-2028)
10.3.5.3. Market Revenue and Forecast, By Test Type (2016-2028)
10.3.6. Japan
10.3.6.1. Market Revenue and Forecast, By Product (2016-2028)
10.3.6.2. Market Revenue and Forecast, By Technique (2016-2028)
10.3.6.3. Market Revenue and Forecast, By Test Type (2016-2028)
10.3.7. Rest of APAC
10.3.7.1. Market Revenue and Forecast, By Product (2016-2028)
10.3.7.2. Market Revenue and Forecast, By Technique (2016-2028)
10.3.7.3. Market Revenue and Forecast, By Test Type (2016-2028)
10.4. MEA
10.4.1. Market Revenue and Forecast, By Product (2016-2028)
10.4.2. Market Revenue and Forecast, By Technique (2016-2028)
10.4.3. Market Revenue and Forecast, By Test Type (2016-2028)
10.4.4. GCC
10.4.4.1. Market Revenue and Forecast, By Product (2016-2028)
10.4.4.2. Market Revenue and Forecast, By Technique (2016-2028)
10.4.4.3. Market Revenue and Forecast, By Test Type (2016-2028)
10.4.5. North Africa
10.4.5.1. Market Revenue and Forecast, By Product (2016-2028)
10.4.5.2. Market Revenue and Forecast, By Technique (2016-2028)
10.4.5.3. Market Revenue and Forecast, By Test Type (2016-2028)
10.4.6. South Africa
10.4.6.1. Market Revenue and Forecast, By Product (2016-2028)
10.4.6.2. Market Revenue and Forecast, By Technique (2016-2028)
10.4.6.3. Market Revenue and Forecast, By Test Type (2016-2028)
10.4.7. Rest of MEA
10.4.7.1. Market Revenue and Forecast, By Product (2016-2028)
10.4.7.2. Market Revenue and Forecast, By Technique (2016-2028)
10.4.7.3. Market Revenue and Forecast, By Test Type (2016-2028)
10.5. Latin America
10.5.1. Market Revenue and Forecast, By Product (2016-2028)
10.5.2. Market Revenue and Forecast, By Technique (2016-2028)
10.5.3. Market Revenue and Forecast, By Test Type (2016-2028)
10.5.4. Brazil
10.5.4.1. Market Revenue and Forecast, By Product (2016-2028)
10.5.4.2. Market Revenue and Forecast, By Technique (2016-2028)
10.5.4.3. Market Revenue and Forecast, By Test Type (2016-2028)
10.5.5. Rest of LATAM
10.5.5.1. Market Revenue and Forecast, By Product (2016-2028)
10.5.5.2. Market Revenue and Forecast, By Technique (2016-2028)
10.5.5.3. Market Revenue and Forecast, By Test Type (2016-2028)
Chapter 11. Company Profiles
11.1. Grifols, S.A.
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. Merck KGaA
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. Bio-Rad Laboratories, Inc.
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. Immucor, Inc.
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. Recent Initiatives
11.5. Novacyt Group
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. Danaher Corporation
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. Agena Bioscience, Inc.
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
11.8. Ortho Clinical Diagnostics
11.8.1. Company Overview
11.8.2. Product Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives
11.9. Quotient, Ltd.
11.9.1. Company Overview
11.9.2. Product Offerings
11.9.3. Financial Performance
11.9.4. Recent Initiatives
Chapter 12. Research Methodology
12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions
Chapter 13. Appendix
13.1. About Us
Glossary of Terms
Cross-segment Market Size and Analysis for
Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers